JPMorgan Asset Management Form8.6(Public)JPM Fund ICVC-JPM UKEquityIndexFund (0821D)
February 14 2020 - 6:34AM
UK Regulatory
TIDMSOPH
RNS Number : 0821D
JPMorgan Asset Management
14 February 2020
FORM 8.6 (Public)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT FUND MANAGER
The Executive has ruled that public disclosure (rather than
private disclosure under Rule 8.6) is required because funds under
management contain seed capital.
1. KEY INFORMATION
(a) Name of exempt fund manager: JPMorgan Fund ICVC - JPM UK Equity Index Fund
(b) Name of offeror/offeree in relation to whose relevant Sophos Group plc
securities this form relates:
Use a separate form for each offeror/offeree
----------------------------------------------------------
(c) Name of the party to the offer with which exempt fund Lead Financial Advisor and Corporate Broker to Sophos
manager is connected: Group PLC
----------------------------------------------------------
(d) Date position held/dealing undertaken: 22 January 2020
For an opening position disclosure, state the latest
practicable date prior to the disclosure
----------------------------------------------------------
(e) In addition to the company in 1(b) above, is the N/A
exempt fund manager making disclosures
in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
----------------------------------------------------------
2. POSITIONS OF THE EXEMPT FUND MANAGER
If there are positions or rights to subscribe to disclose in
more than one class of relevant securities of the same offeror or
offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for
each additional class of relevant security.
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates following
the dealing
Class of relevant security: Ordinary Share
Interests Short positions
-------------- ------------------
Number % Number %
------- ----- ---------- ------
(1) Relevant securities owned and/or controlled: 3,788 0.00 0 0.00
------- ----- ---------- ------
(2) Cash-settled derivatives:
------- ----- ---------- ------
(3) Stock-settled derivatives (including options) and agreements to
purchase/sell:
------- ----- ---------- ------
TOTAL: 3,788 0.00 0 0.00
------- ----- ---------- ------
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions
(including traded options), or agreements to purchase or sell
relevant securities, should be given on a Supplemental Form 8 (Open
Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options)
Ordinary Share
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
3. DEALINGS BY THE EXEMPT FUND MANAGER
Where there have been dealings in more than one class of
relevant securities of the offeror or offeree named in 1(b), copy
table 3(a), (b), (c) or (d) (as appropriate) for each additional
class of relevant security dealt in.
The currency of all prices and other monetary amounts should be
stated.
(a) Purchases and sales
Class of relevant security Purchase/sale Number of securities Price per unit
Ordinary Share Purchase 1,198 5.6100 GBP
-------------- --------------------- ---------------
(b) Cash-settled derivative transactions
Class of relevant Product description Nature of dealing Number of reference Price per unit
security e.g. CFD e.g. opening/closing a securities
long/short position,
increasing/reducing a
long/short position
Ordinary Share
-------------------- ------------------------- ------------------------- ---------------
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, Number of Exercise Type Expiry date Option money
relevant description purchasing, securities price per e.g. paid/
security e.g. call selling, to which unit American, received per
option varying etc. option European unit
relates etc.
Ordinary
Share
------------- ------------- ------------- -------------- ------------- ------------ -------------
(ii) Exercise
Class of relevant Product description Exercising/ exercised Number of securities Exercise price per
security e.g. call option against unit
Ordinary Share
-------------------- ----------------------- --------------------- -----------------------
(d) Other dealings (including subscribing for new securities)
Class of relevant security Nature of dealing Details Price per unit (if applicable)
e.g. subscription, conversion
Ordinary Share
------------------------------- -------- -------------------------------
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal
or informal, relating to relevant securities which may be an inducement to deal or refrain
from dealing entered into by the exempt fund manager making the disclosure and any party to
the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such
agreements, arrangements or understandings, state "none"
None
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the exempt
fund manager making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which
any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
None
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 14 February 2020
Contact name: Daniel Swart
-----------------
Telephone number: 0207 134 6168
-----------------
Public disclosures under Rule 8 of the Code must be made to a
Regulatory Information Service.
The Panel's Market Surveillance Unit is available for
consultation in relation to the Code's disclosure requirements on
+44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at
www.thetakeoverpanel.org.uk .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DCCEAFALFDFEEFA
(END) Dow Jones Newswires
February 14, 2020 06:34 ET (11:34 GMT)
Sophos (LSE:SOPH)
Historical Stock Chart
From Jul 2024 to Aug 2024
Sophos (LSE:SOPH)
Historical Stock Chart
From Aug 2023 to Aug 2024